跳至主要内容
临床试验/NCT04622722
NCT04622722已完成不适用

Efficacy and Safety of Diabetes-specific Formula in Patients With Type 2 Diabetes Mellitus

Société des Produits Nestlé (SPN)2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年8月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
2-hour postprandial glucose

研究概览

简要总结

Hypothesis: the diabetes-specific formula Nutren diabetes provides better postprandial glucose control in patients with type 2 diabetes when compared to the isocaloric diet.

详细描述

This study is an open label, randomized controlled cross-over study

Research objectives:

  1. To study the efficacy of diabetes-specific formula (Nutren Diabetes) in comparison with an isocaloric diet in the aspect of postprandial blood glucose and insulin response (baseline, 30, 60 and 120 minute).
  2. To study the safety and tolerance of a diabetes-specific formula compared with an isocaloric diet in patients with type 2 diabetes mellitus

Statistical analysis method

  1. Descriptive statistics: categorical data will be summarized as number and percentage, continuous data with normal distribution will be presented as means and standard deviations, and continuous data with non-normal distribution will be summarized as median, minimum and maximum.
  2. Inferential statistics: Repeated Measure ANOVA from analyzing the difference of means from measuring fasting glucose and insulin more than two times.
  3. Inferential statistics: Paired T-Test or Wilcoxon Matched pairs Signed Rank Test derived by analyzing the comparison between the means of two dependent groups.
  4. Report of the difference between two categories by the difference of means with 95% Confidence Interval
  5. Number of participant (subjects) and criteria for participation 30 participants by calculation formula of Frison and Pocock (1992) with STATA program.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DM type 2, HbA1C < 9% FPG < 180 mg/dl
  • Aged between 18- 70 years.
  • Participants must have stable body weight (+/- not over 5%) for the past six months.
  • Participants must control their diabetes by diet control or taking diabetes medicine without medicine dose adjustment during the period of the research.
  • Participants are willing to participate in the research and sign written consent form.

排除标准

  • Participants receive insulin hormone and GPL-1 agonist injection.
  • GFR < 30 ml/min/1.73 m2
  • Participants have decompensated liver cirrhosis or alcoholism or drug abuse record.
  • Participants have record of allergy to any ingredients in diabetes-specific formula,soybean milk or bologna and mayonnaise sandwich.
  • Participants decline to participate

结局指标

主要结局

2-hour postprandial glucose

时间窗: Change form baseline blood glucose level at 30,60, and 120 min.

The primary outcome will be the difference of 2-hour postprandial glucose between group A and group B

次要结局

  • Area under the curve of postprandial plasma insulin (AUC insulin 0-120 min)(Postprandial plasma insulin response at 0, 30, 60,120 min)
  • Area under the curve of postprandial plasma glucose (AUC glucose 0-120 min)(Time Frame: Postprandial blood glucose response at 0, 30, 60,120 min)
  • Gastrointestinal tolerance(7 days prior to the treatment phase.)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验